The Net Margin of Glenmark Pharmaceuticals Ltd (GLENMARK.NS) is 7.86%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-03-31 | 7.86% |
| 2024-03-31 | -12.71% |
| 2023-03-31 | 2.57% |
| 2022-03-31 | 7.65% |
| 2021-03-31 | 8.86% |
| 2020-03-31 | 7.29% |
| 2019-03-31 | 9.38% |
| 2018-03-31 | 8.50% |
| 2017-03-31 | 9.97% |
| 2016-03-31 | 9.18% |